Search Results

Case Files

Unexpected Field Changes

Testing demonstrates improvement after surgery.

Devesh K. Varma, MD, FRCSC; Ronald L. Fellman, MD; Andrew Gross, MD; and Kelly W. Muir, MD, MHSc

Bench To Bedside

What Is the Real IOP?

Laboratory studies may help us better understand our clinical dilemmas.

Dan Eisenberg, MD

Landmark Studies

Glaucoma Therapy Delivers Great Patient and Financial Value

The cost-utility analysis associated with glaucoma therapy.

Gary C. Brown, MD, MBA; Joshua D. Stein, MD, MSc, MS; Melissa M. Brown, MD, MN, MBA; Richard P. Wilson, MD; and George L. Spaeth, MD

Landmark Studies

Costs and Financial Gain Associated With Glaucoma Therapy

Ophthalmic interventions deliver significant patient and financial value.

Gary C. Brown, MD, MBA; Melissa M. Brown, MD, MN, MBA; Joshua D. Stein, MD, MSc, MS; Richard P. Wilson, MD; and George L. Spaeth, MD

Identifying and Managing Early Glaucoma

RONALD L. GROSS, MD

Practical Aspects of Glaucoma Care

Glaucoma specialists discuss the impact of recent studies on clinical practice.

Evidence-based Best Practices for Glaucoma Care

Maximizing the Benefits of Topical Therapy

Cost is a factor, but it does not trump efficacy, safety, or tolerability.

RONALD L. GROSS, MD, AND RYAN D. VINCENT, MD

Improving the Efficiency of Perimetry

Customizing visual field testing for individual patients can save time and keep our patients upbeat for this essential examination.

Ronald L. Fellman, MD